Furthermore, since GLP-1 signaling was suggested as a common pathophysiological mechanism in both Alzheimer’s disease and T2DM, GLP-1 agonists may prevent cognitive decline (68). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.